Neuland Laboratories Limited — Others, 17-06-2025: Action(s) taken or orders passed

Neuland Laboratories has announced a warning from SEBI addressed to a designated person of the company for violating insider trading norms related to transaction pre-clearance. This compliance issue does not have any material impact on the company’s financials or operations. The notice highlights the importance of adhering to insider trading rules to maintain governance standards, but current business activities remain unaffected.